[
    [
        {
            "time": "",
            "original_text": "生物制品Ⅱ行业投资策略报告：狂犬疫苗供不应求 提价显著增厚业绩",
            "features": {
                "keywords": [
                    "狂犬疫苗",
                    "供不应求",
                    "提价",
                    "业绩"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物制品"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "生物制品Ⅱ行业投资策略报告：狂犬疫苗供不应求 提价显著增厚业绩",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "智飞生物现2笔大宗交易 共成交722.93万元",
            "features": {
                "keywords": [
                    "智飞生物",
                    "大宗交易",
                    "成交额"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物制品"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "智飞生物现2笔大宗交易 共成交722.93万元",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "医药行业周报：智飞生物新冠疫苗启动Ⅱ期临床，疫苗板块持续走强",
            "features": {
                "keywords": [
                    "智飞生物",
                    "新冠疫苗",
                    "Ⅱ期临床",
                    "疫苗板块",
                    "走强"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物制品"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药行业周报：智飞生物新冠疫苗启动Ⅱ期临床，疫苗板块持续走强",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "智飞生物、爱尔眼科、康泰生物、沃森生物集体大涨并创新高，力撑创业板指",
            "features": {
                "keywords": [
                    "智飞生物",
                    "爱尔眼科",
                    "康泰生物",
                    "沃森生物",
                    "大涨",
                    "创新高",
                    "创业板指"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物制品"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "智飞生物、爱尔眼科、康泰生物、沃森生物集体大涨并创新高，力撑创业板指",
                "Correlation": 8,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 9,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "【医药】智飞生物新冠疫苗启动Ⅱ期临床，疫苗板块持续走强——医药行业周报——中性（联系人：甘英健、陈晨、张山峰）",
            "features": {
                "keywords": [
                    "智飞生物",
                    "新冠疫苗",
                    "Ⅱ期临床",
                    "疫苗板块",
                    "走强",
                    "中性"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物制品"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【医药】智飞生物新冠疫苗启动Ⅱ期临床，疫苗板块持续走强——医药行业周报——中性（联系人：甘英健、陈晨、张山峰）",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]